Compare LXRX & SATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LXRX | SATL |
|---|---|---|
| Founded | 1995 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 465.2M | 482.3M |
| IPO Year | 2000 | N/A |
| Metric | LXRX | SATL |
|---|---|---|
| Price | $1.82 | $4.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $3.23 | ★ $5.00 |
| AVG Volume (30 Days) | 2.1M | ★ 8.2M |
| Earning Date | 03-05-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $70,864,000.00 | $14,684,000.00 |
| Revenue This Year | $56.61 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1255.21 | N/A |
| 52 Week Low | $0.28 | $1.26 |
| 52 Week High | $1.66 | $5.12 |
| Indicator | LXRX | SATL |
|---|---|---|
| Relative Strength Index (RSI) | 79.59 | 80.25 |
| Support Level | $1.25 | $3.28 |
| Resistance Level | $1.41 | $3.83 |
| Average True Range (ATR) | 0.10 | 0.45 |
| MACD | 0.07 | 0.14 |
| Stochastic Oscillator | 99.24 | 95.02 |
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.